ciprofloxacin has been researched along with Heart Valve Diseases in 7 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
| Excerpt | Relevance | Reference |
|---|---|---|
| "No ciprofloxacin resistance was detected among Pseudomonas isolates from cardiac vegetations." | 1.27 | Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production. ( Bayer, AS; Blomquist, IK; Hirano, L; Lee, D; Lindsay, P; Yih, J, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Xiang, B | 2 |
| Abudupataer, M | 2 |
| Liu, G | 2 |
| Zhou, X | 2 |
| Liu, D | 2 |
| Zhu, S | 2 |
| Ming, Y | 2 |
| Yin, X | 2 |
| Yan, S | 2 |
| Sun, Y | 2 |
| Lai, H | 2 |
| Wang, C | 2 |
| Li, J | 2 |
| Zhu, K | 2 |
| Algaidi, SH | 1 |
| Alghamdi, DI | 1 |
| Algheffari, SG | 1 |
| Alzahrani, RA | 1 |
| Thabit, AK | 1 |
| Hafiz, AM | 1 |
| Schjøtt, J | 1 |
| Messner, T | 1 |
| Naba, MR | 1 |
| Araj, GF | 1 |
| Kanafani, ZA | 1 |
| Kanj, SS | 1 |
| Ebnöther, C | 1 |
| Altwegg, M | 1 |
| Gottschalk, J | 1 |
| Seebach, JD | 1 |
| Kronenberg, A | 1 |
| Daikos, GL | 1 |
| Kathpalia, SB | 1 |
| Lolans, VT | 1 |
| Jackson, GG | 1 |
| Fosslien, E | 1 |
| Bayer, AS | 1 |
| Lindsay, P | 1 |
| Yih, J | 1 |
| Hirano, L | 1 |
| Lee, D | 1 |
| Blomquist, IK | 1 |
7 other studies available for ciprofloxacin and Heart Valve Diseases
| Article | Year |
|---|---|
Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm.
Topics: Animals; Aortic Aneurysm, Thoracic; Aortic Valve; Bicuspid Aortic Valve Disease; Ciprofloxacin; Hear | 2023 |
Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm.
Topics: Animals; Aortic Aneurysm, Thoracic; Aortic Valve; Bicuspid Aortic Valve Disease; Ciprofloxacin; Hear | 2023 |
Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm.
Topics: Animals; Aortic Aneurysm, Thoracic; Aortic Valve; Bicuspid Aortic Valve Disease; Ciprofloxacin; Hear | 2023 |
Ciprofloxacin exacerbates dysfunction of smooth muscle cells in a microphysiological model of thoracic aortic aneurysm.
Topics: Animals; Aortic Aneurysm, Thoracic; Aortic Valve; Bicuspid Aortic Valve Disease; Ciprofloxacin; Hear | 2023 |
Long-term Cardiovascular Adverse Events Induced by Fluoroquinolones: A Retrospective Case-control Study.
Topics: Case-Control Studies; Ciprofloxacin; Fluoroquinolones; Heart Valve Diseases; Humans; Levofloxacin; M | 2023 |
Ciprofloxacin and acute aortic valve damage.
Topics: Aged; Aortic Valve; Arthroplasty, Replacement, Knee; Ciprofloxacin; Cloxacillin; Collagen; Fluoroqui | 2018 |
First case of Pasteurella multocida endocarditis of the tricuspid valve: a favorable outcome following medical treatment.
Topics: Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Blood; Ciprofloxacin; Culture Media; Echocardi | 2009 |
Endocarditis after urinary tract infection.
Topics: Aged; Anti-Infective Agents; Aortic Valve; Ciprofloxacin; Diagnosis, Differential; Echocardiography, | 2002 |
Long-term oral ciprofloxacin: experience in the treatment of incurable infective endocarditis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Drug Administration Schedule; E | 1988 |
Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production.
Topics: Animals; Aortic Valve; Ceftazidime; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacteri | 1986 |